Impact Biomedical Inc. (IBO)
Market Closed
27 Jul, 20:00
AMEX AMEX Primary $
0. 43
-0.01
-1.8182%
$
5.51M Market Cap
- P/E Ratio
- Div Yield
14,131 Volume
- Eps
$ 0.44
Previous Close Investors:
Want to track IBO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Impact Biomedical Inc. (IBO) Statistics
Valuation metrics
Market Cap 5.51M
Enterprise value 5.48M
Trailing P/E (ttm) -0.35
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) 141.03
Price/Book (mrq) 4.14
Enterprise Value/Revenue 140.51
Enterprise Value/EBITDA -0.4
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 12.64K
Average volume (90 days) 48.6K
Price summary
52-Week low 0.37
52-Week high 0.83
Beta -
50-Day moving average 0.45
200-Day moving average 0.52
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 5 Jun 2020
Ex-Dividend Date 14 May 2020
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -329.69%
Operating margin -117.82%
Operational effectiveness
Return on assets -0.75%
Return on equity -26.75%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.12
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 0.22%
Book value per share (mrq) 0.14
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
